4.7 Letter

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]

Journal

DIABETOLOGIA
Volume 53, Issue 1, Pages 209-211

Publisher

SPRINGER
DOI: 10.1007/s00125-009-1582-6

Keywords

Cancer; Diabetes; Drug safety; Glargine; Human insulin; Insulin analogues

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available